MetabolicIn Clinical Trials

Danuglipron

Oral

Overview

Danuglipron is an oral, non-peptide small-molecule agonist of the GLP-1 receptor developed to provide convenient daily dosing for type 2 diabetes and obesity. It mimics the effects of endogenous GLP-1 by enhancing glucose-dependent insulin secretion, suppressing glucagon, and slowing gastric emptying.

Mechanism of Action

The small-molecule structure enables oral bioavailability without the need for injection..

Research Summary & Key Findings

Phase 2 studies in type 2 diabetes showed dose-dependent reductions in HbA1c and body weight, with data presented at diabetes conferences in 2022 and 2023. Gastrointestinal tolerability challenges were noted, prompting evaluation of modified dosing regimens. Further clinical development is ongoing to optimize therapeutic benefit and adherence.

Clinical Status

In Clinical Trials

Danuglipron is currently undergoing clinical trials. It is not yet FDA-approved and is available only through clinical research settings or investigational protocols.

Administration Routes

Oral

Related Peptides in Metabolic

Semaglutide (Ozempic/Wegovy)

FDA Approved

A glucagon-like peptide-1 receptor agonist (GLP-1 RA) with 94% amino acid homology to native GLP-1. Semaglutide enhances...

View details

Tirzepatide (Mounjaro/Zepbound)

FDA Approved

A first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Tirzepatide activat...

View details

Retatrutide

In Clinical Trials

An investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The gluc...

View details

AOD-9604

Investigational

A modified 16-amino acid fragment (amino acids 176-191) of the C-terminus of human growth hormone with an added tyrosine...

View details

Find a Provider

Find a verified provider who offers Danuglipron therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Danuglipron.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.